![Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00125-022-05787-2/MediaObjects/125_2022_5787_Fig5_HTML.png)
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia
![PDF) 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) PDF) 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)](https://0.academia-photos.com/attachment_thumbnails/81175272/mini_magick20220221-331-74liue.png?1645464299)
PDF) 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
![Trial results support latest ADA/EASD guidelines on role of SGLT-2 inhibitors in managing type 2 diabetes – EASD e-Learning Trial results support latest ADA/EASD guidelines on role of SGLT-2 inhibitors in managing type 2 diabetes – EASD e-Learning](https://easd-elearning.org/wp-content/uploads/2020/10/SGLT2.png)
Trial results support latest ADA/EASD guidelines on role of SGLT-2 inhibitors in managing type 2 diabetes – EASD e-Learning
![2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee | Journal 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee | Journal](https://www.jacc.org/cms/asset/235fee8d-1af1-43f2-8849-c6806670cc30/j.jacc.2020.05.037.fp.png)
2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee | Journal
![Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus. - Abstract - Europe PMC Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7223028/bin/bmjdrc-2020-001248f02.jpg)
Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus. - Abstract - Europe PMC
![Diabetes Typ-2 personalisiert behandeln! Paradigmenwechsel in der gemeinsamen Therapie-Leitlinie 2018 der Amerikanischen (ADA) und Europäischen (EASD) Diabetesgesellschaft | DGE Blog Diabetes Typ-2 personalisiert behandeln! Paradigmenwechsel in der gemeinsamen Therapie-Leitlinie 2018 der Amerikanischen (ADA) und Europäischen (EASD) Diabetesgesellschaft | DGE Blog](https://blog.endokrinologie.net/wp-content/uploads/2018/11/ADA-EASD-Guidelines-2018-2.jpg)
Diabetes Typ-2 personalisiert behandeln! Paradigmenwechsel in der gemeinsamen Therapie-Leitlinie 2018 der Amerikanischen (ADA) und Europäischen (EASD) Diabetesgesellschaft | DGE Blog
![2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00125-019-05039-w/MediaObjects/125_2019_5039_Fig1_HTML.png)
2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia
![The new ADA/EASD guideline: A huge leap forward in the treatment of type 2 diabetes - DiabetesontheNet The new ADA/EASD guideline: A huge leap forward in the treatment of type 2 diabetes - DiabetesontheNet](https://diabetesonthenet.com/wp-content/uploads/imagesmol/dotngmdJDN034_Down_Figure_1_HR.png)
The new ADA/EASD guideline: A huge leap forward in the treatment of type 2 diabetes - DiabetesontheNet
![Figure 6 from Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Semantic Scholar Figure 6 from Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1845ac53c5b63f4f094e4671ba7b3062f430f037/10-Figure6-1.png)
Figure 6 from Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Semantic Scholar
![Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00125-022-05787-2/MediaObjects/125_2022_5787_Fig1_HTML.png)
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia
![PDF) Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus PDF) Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus](https://i1.rgstatic.net/publication/341145667_Recommendations_for_management_of_diabetes_during_Ramadan_update_2020_applying_the_principles_of_the_ADAEASD_consensus/links/5eb0c755a6fdcc7050a97e0a/largepreview.png)
PDF) Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus
![ADA/EASD consensus update on management of hyperglycaemia in type 2 diabetes – report published in Diabetologia and Diabetes Care – Diabetologia ADA/EASD consensus update on management of hyperglycaemia in type 2 diabetes – report published in Diabetologia and Diabetes Care – Diabetologia](https://diabetologia-journal.org/wp-content/uploads/2022/09/Screenshot-2022-09-21-at-13.20.37.png)
ADA/EASD consensus update on management of hyperglycaemia in type 2 diabetes – report published in Diabetologia and Diabetes Care – Diabetologia
![Cardiovascular Disease, Technology and Personalized Care Highlighted in ADA's 2020 Standards of Medical Care in Diabetes | Markets Insider Cardiovascular Disease, Technology and Personalized Care Highlighted in ADA's 2020 Standards of Medical Care in Diabetes | Markets Insider](https://mma.prnewswire.com/media/1058438/American_Diabetes_Association.jpg)
Cardiovascular Disease, Technology and Personalized Care Highlighted in ADA's 2020 Standards of Medical Care in Diabetes | Markets Insider
![Glucose-lowering therapy in patients undergoing percutaneous coronary intervention | EuroIntervention Glucose-lowering therapy in patients undergoing percutaneous coronary intervention | EuroIntervention](https://eurointervention.pcronline.com/storage/issues/EIJ196e/112_EIJ-D-20-01250_Johansson_196e/medias/630560/tab06_Johansson_196e.jpg)
Glucose-lowering therapy in patients undergoing percutaneous coronary intervention | EuroIntervention
![Ana Piera #JuntosEsMasFacil #StopInercia on X: "2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes ... Ana Piera #JuntosEsMasFacil #StopInercia on X: "2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes ...](https://pbs.twimg.com/media/EO6s6lpWAAETE0i.jpg)
Ana Piera #JuntosEsMasFacil #StopInercia on X: "2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes ...
Scholarly Article or Book Chapter | 2019 update to: Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the
![New EASD-ADA consensus guidelines on managing hyperglycaemia in type 2 diabetes launched at EASD meeting. New recommendations include specific drug classes for some patients and enhancing medication adherence – Diabetologia New EASD-ADA consensus guidelines on managing hyperglycaemia in type 2 diabetes launched at EASD meeting. New recommendations include specific drug classes for some patients and enhancing medication adherence – Diabetologia](https://diabetologia-journal.org/wp-content/uploads/2018/09/Fig-2-for-EASD-ADA.jpg)
New EASD-ADA consensus guidelines on managing hyperglycaemia in type 2 diabetes launched at EASD meeting. New recommendations include specific drug classes for some patients and enhancing medication adherence – Diabetologia
![SGLT2 inhibitors-what do guidelines say? a The EASD and the ADA jointly... | Download Scientific Diagram SGLT2 inhibitors-what do guidelines say? a The EASD and the ADA jointly... | Download Scientific Diagram](https://www.researchgate.net/publication/335525934/figure/fig1/AS:798007805100039@1567271295865/SGLT2-inhibitors-what-do-guidelines-say-a-The-EASD-and-the-ADA-jointly-published-a.png)
SGLT2 inhibitors-what do guidelines say? a The EASD and the ADA jointly... | Download Scientific Diagram
![Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus. - Abstract - Europe PMC Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7223028/bin/bmjdrc-2020-001248f01.jpg)